STA
AGN

Summit Trail Advisors’s Allergan plc AGN Stock Holding History

Summit Trail Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,421
Closed -$1.26M – 141
2018
Q4 		$1.26M Sell
9,421
-5,825
-38% -$955K 0.45% 34
2018
Q3 		$2.9M Buy
15,246
+554
+4% +$102K 0.64% 31
2018
Q2 		$2.45M Sell
14,692
-8,075
-35% -$1.3M 0.86% 17
2018
Q1 		$1.2M Buy
22,767
+14,042
+161% +$2.36M 0.2% 111
2017
Q4 		$1.59M Buy
+8,725
New +$1.57M 0.2% 98

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Summit Trail Advisors's AGN Position: Q1 2019 in Review

Summit Trail Advisors sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 9,421 shares — an estimated $1.26M sold.

Summit Trail Advisors first reported a position in AGN in Q4 2017 and held it in 5 quarters. The position peaked at $2.9M in Q3 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Summit Trail Advisors reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Summit Trail Advisors sold 9,421 Allergan plc shares in Q1 2019, an estimated $1.26M.
  • Summit Trail Advisors first reported a position in Allergan plc in Q4 2017 and held it in 5 quarters.
  • Summit Trail Advisors's Allergan plc position peaked at $2.9M in Q3 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Summit Trail Advisors's 13F filing for Q1 2019, filed 16 May 2019.